Prevnar 13
E474933
Prevnar 13 is a pneumococcal conjugate vaccine that protects against 13 serotypes of Streptococcus pneumoniae, helping prevent invasive pneumococcal disease and pneumonia, especially in children and older adults.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Prevnar 13 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4850381 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Prevnar 13 Context triple: [Pfizer, developed, Prevnar 13]
-
A.
Gardasil
Gardasil is a widely used human papillomavirus (HPV) vaccine that helps prevent cervical and other HPV-related cancers and diseases.
-
B.
Sinovac
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
C.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
D.
BCG vaccine
The BCG vaccine is a widely used immunization that primarily protects against severe forms of tuberculosis, especially in young children.
-
E.
Opekta
Opekta was a German-Dutch company that produced and sold pectin-based gelling agents for making jam, notably managed in its Amsterdam branch by Anne Frank’s father, Otto Frank.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Prevnar 13 Target entity description: Prevnar 13 is a pneumococcal conjugate vaccine that protects against 13 serotypes of Streptococcus pneumoniae, helping prevent invasive pneumococcal disease and pneumonia, especially in children and older adults.
-
A.
Gardasil
Gardasil is a widely used human papillomavirus (HPV) vaccine that helps prevent cervical and other HPV-related cancers and diseases.
-
B.
Sinovac
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
C.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
D.
BCG vaccine
The BCG vaccine is a widely used immunization that primarily protects against severe forms of tuberculosis, especially in young children.
-
E.
Opekta
Opekta was a German-Dutch company that produced and sold pectin-based gelling agents for making jam, notably managed in its Amsterdam branch by Anne Frank’s father, Otto Frank.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
pneumococcal conjugate vaccine
ⓘ
vaccine ⓘ |
| administeredByRoute | intramuscular injection ⓘ |
| approvedBy | U.S. Food and Drug Administration NERFINISHED ⓘ |
| approvedIn |
European Union
NERFINISHED
ⓘ
United States NERFINISHED ⓘ |
| ATCCode | J07AL02 ⓘ |
| containsAntigenType | polysaccharide ⓘ |
| containsCarrierProtein | CRM197 NERFINISHED ⓘ |
| developedBy | Wyeth Pharmaceuticals NERFINISHED ⓘ |
| dosageForm | suspension for injection ⓘ |
| firstApprovedYear | 2009 ⓘ |
| hasGenericName | pneumococcal 13-valent conjugate vaccine ⓘ |
| hasManufacturer | Pfizer NERFINISHED ⓘ |
| indicatedFor |
adults 18 years and older with certain risk factors
ⓘ
adults 50 years and older ⓘ children ⓘ infants ⓘ older adults ⓘ |
| isConjugatedTo | CRM197 diphtheria protein NERFINISHED ⓘ |
| marketedAs | Prevenar 13 NERFINISHED ⓘ |
| prevents |
invasive pneumococcal disease
ⓘ
pneumococcal pneumonia ⓘ |
| protectsAgainst | Streptococcus pneumoniae NERFINISHED ⓘ |
| protectsAgainstSerotype |
1
ⓘ
14 ⓘ 18C ⓘ 19A ⓘ 19F ⓘ 23F ⓘ 3 ⓘ 4 ⓘ 5 ⓘ 6A ⓘ 6B ⓘ 7F ⓘ 9V ⓘ |
| protectsAgainstSerotypeCount | 13 ⓘ |
| recommendedBy |
Advisory Committee on Immunization Practices
NERFINISHED
ⓘ
World Health Organization NERFINISHED ⓘ |
| recommendedIn | childhood immunization schedule ⓘ |
| replacedProduct | Prevnar NERFINISHED ⓘ |
| replacedValent | 7-valent pneumococcal conjugate vaccine ⓘ |
| storageTemperature | 2-8 °C ⓘ |
| targetPathogen | Streptococcus pneumoniae NERFINISHED ⓘ |
| targetPopulation |
immunocompetent children
ⓘ
immunocompromised individuals at risk for pneumococcal disease ⓘ |
| usedFor | pneumococcal disease prevention ⓘ |
| valency | 13-valent ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Prevnar 13 Description of subject: Prevnar 13 is a pneumococcal conjugate vaccine that protects against 13 serotypes of Streptococcus pneumoniae, helping prevent invasive pneumococcal disease and pneumonia, especially in children and older adults.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.